» Authors » Barbara Wieckowska

Barbara Wieckowska

Explore the profile of Barbara Wieckowska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacka K, Maciejewski A, Tyburski P, Manuszewska-Jopek E, Majewski P, Wieckowska B
Int J Mol Sci . 2025 Feb; 26(3). PMID: 39940804
The p53 protein is a tumor-suppressing transcription factor that is critical in tumorigenesis. While mutations are rare in differentiated thyroid cancer (DTC), they are significantly more common in anaplastic thyroid...
2.
Stanislawiak-Rudowicz J, Szalek E, Wieckowska B, Grzeskowiak E, Madry R
Pharmacol Rep . 2025 Jan; PMID: 39881056
Background: Olaparib is a relatively new poly(ADP-ribose) polymerase inhibitor (PARPi) administered to ovarian cancer (OC) patients with a complete or partial response to first-line chemotherapy. One of the metabolic side...
3.
Luchowska K, Chmielewska M, Byszek K, Olearczyk A, Gawronska A, Wieckowska B
BMJ Open . 2025 Jan; 14(12):e088169. PMID: 39806600
Introduction: Integrating digital health technologies to improve the overall performance of healthcare systems counts among the top priorities of the WHO. As evidenced in recent research, there are specific factors...
4.
Barelkowska M, Wieckowska B, Borowczyk M, Derwich K
Pediatr Blood Cancer . 2024 Dec; 72(3):e31494. PMID: 39694872
Background: Enhancing therapy outcomes in pediatric oncology and hematology relies on robust epidemiological surveillance. This study aimed to estimate cancer stage-related survival in pediatric patients with lymphoma and solid tumors...
5.
Mlynarz N, Miedziaszczyk M, Wieckowska B, Szalek E, Lacka K
Int J Mol Sci . 2024 Nov; 25(22). PMID: 39596286
Metabolic syndrome (MS) comprises several symptoms or disorders that significantly increase the risk of developing atherosclerosis and type 2 diabetes. This study aims to determine the direct impact of testosterone...
6.
Pytka M, Domin R, Zolynski M, Nizinski J, Krauze T, Wieckowska B, et al.
PLoS One . 2024 Nov; 19(11):e0313165. PMID: 39495753
Background: Endurance training enhances exercise capacity and triggers cardiovascular adaptations in both males and females. We investigated the relationship between the dimensions of great vessels and exercise capacity in amateur...
7.
Stanislawiak-Rudowicz J, Szalek E, Adamiak A, Urjasz H, Wieckowska B, Grzeskowiak E, et al.
Rep Pract Oncol Radiother . 2024 Aug; 29(1):113-121. PMID: 39165599
Background: Olaparib is the first poly(ADP-ribose) polymerase inhibitor approved in Europe for the treatment of platinum-sensitive patients with newly diagnosed or recurrent platinum-sensitive ovarian cancer with a confirmed BRCA mutation...
8.
Matuszewska K, Bukowska-Olech E, Piechota M, Staniek-Lacna K, Drews K, Wieckowska B, et al.
J Matern Fetal Neonatal Med . 2024 Jul; 37(1):2364249. PMID: 39069503
Objective: To determine the frequency of chromosomal aberrations in chorions after a miscarriage. The second was to examine selected euploid chorions using a next-generation sequencing (NGS) panel designed to assess...
9.
Roszak M, Breborowicz A, Szczepankiewicz A, Mikos M, Bukowy-Bieryllo Z, Wieckowska B, et al.
Adv Respir Med . 2024 Jul; 92(4):254-262. PMID: 39051187
In recent years, questionnaires were published in English to assess the quality of life of patients with PCD (Primary Ciliary Diskinesia) for adults, adolescents aged 13-17 years, and children aged...
10.
Wieckowska B, Byszek K, Rekas M, Yurochko T, Shevchenko M, Skrypnikova O, et al.
PLoS One . 2024 Jul; 19(7):e0306562. PMID: 38980859
Objectives: The article aims to compare payment schemes for cataract, glaucoma, vitrectomy, cornea transplantations, DME, and AMD across Hungary, Poland, and Ukraine, and to identify implementable practices in Ukraine within...